Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
IMX > SEC Filings for IMX > Form 8-K on 6-Jan-2009All Recent SEC Filings

Show all filings for IMPLANT SCIENCES CORP | Request a Trial to NEW EDGAR Online Pro

Form 8-K for IMPLANT SCIENCES CORP


6-Jan-2009

Change in Directors or Principal Officers, Regulation FD Disclosure, Financ


Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On December 30, 2008, at the request of Phillip C. Thomas, the Board of Directors accepted Mr. Thomas's resignation as President, Chief Executive Officer and Chairman of the Board of the Company effective December 31, 2008. Mr. Thomas indicated that his resignation was due to a personal decision to pursue other interests and not as a result of any disagreements with the Company's management or Board of Directors.

On December 30, 2008, the Board of Directors appointed Glenn D. Bolduc as the Company's President and Chief Executive Officer. Mr. Bolduc was also appointed as a director of the Company. These appointments were effective January 1, 2009. Mr. Bolduc has served as the Company's Chief Financial Officer since July 2008, a position that Mr. Bolduc will continue to hold. Prior to his appointment as Chief Financial Officer, he was a principal of Radius Advisors, LLC, where he provided advisory services to a number of high technology and services businesses. Prior to 2001, Mr. Bolduc served as chief financial officer of Connected Corporation, a developer of backup software for personal and laptop computers. Previously, Mr. Bolduc served as president and chief executive officer of Vialog Corporation, a consolidator in the teleconferencing service bureau industry, and as chief financial officer of MultiLink, Inc., Concord Data Systems, Inc. and Kronos, Inc. Mr. Bolduc began his career at Price Waterhouse & Company. He holds a Bachelor of Science degree in accounting from Fairleigh Dickinson University.



Item 7.01. Regulation FD Disclosure

On December 31, 2008, the Company issued a press release announcing the resignation of Phillip C. Thomas as President, Chief Executive Officer and Chairman; the appointment of Glenn D. Bolduc as President and Chief Executive Officer; and the appointment of Mr. Bolduc as a director. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by this reference. The press release and the information in Item 7.01 of this Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall they be deemed incorporated by reference in any filing under the Securities Act, except as shall be expressly set forth by specific reference in such filing.



Item 9.01. Financial Statements and Exhibits

(d) Exhibits

Exhibit No. Description

99.1 Press Release of Implant Sciences Corporation dated January 6, 2009.


  Add IMX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for IMX - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.